Literature DB >> 10347119

In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation.

K Ikeda1, T Wakahara, Y Q Wang, H Kadoya, N Kawada, K Kaneda.   

Abstract

In liver injury, hepatic stellate cells are considered to depart from the sinusoidal wall and accumulate in the necrotic lesion through migration and proliferation. In this study, we investigated the migratory capacity of quiescent stellate cells in vitro and analyzed the relationship with proliferative response. Freshly isolated stellate cells that were seeded in the upper chamber of Cell Culture Insert (Becton Dickenson, Franklin Lakes, NJ) started to migrate to the lower chamber at 1 day and increased in migration index to 19% at 2 days. Cells in the lower chamber were stretched in shape with many lipid droplets and showed quiescent properties, i.e., negative expression of alpha-smooth muscle actin (alpha-SMA) or platelet-derived growth factor receptor-beta (PDGFR-beta). Migratory capacity in quiescent cells was also shown in the Matrigel-coated insert. Matrix metalloproteinase-2 (MMP-2) messenger RNA expression was low just after isolation, but was enhanced as migration became prominent. Migrating cells further showed higher proliferative activity than resting ones. The presence of PDGF/BB and Kupffer cells accelerated stellate cell migration by the chemotactic mechanism and concurrently augmented proliferation, whereas that of dexamethasone and interferon-gamma (IFN-gamma) attenuated migration as a result of general suppression effects. Compared with quiescent ones, alpha-SMA and PDGFR-beta-positive activated stellate cells obtained by 14-day culture exhibited more rapid and prominent migration, being regulated by mediators in a similar manner as described previously. These data indicate that quiescent stellate cells undergo migration, which is linked to proliferation and enhanced by PDGF/BB and Kupffer cells, suggesting the involvement of this function in the initial phase of development of postnecrotic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347119     DOI: 10.1002/hep.510290640

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

1.  Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.

Authors:  Mark A Barnes; Megan R McMullen; Sanjoy Roychowdhury; Nabil Z Madhun; Kathryn Niese; Mitchell A Olman; Abram B Stavitsky; Richard Bucala; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2014-11-14       Impact factor: 4.962

2.  Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats.

Authors:  Yan-Jun Luo; Jie-Ping Yu; Zhao-Hong Shi; Li Wang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

3.  Hepatic progenitor cells in chronic hepatitis C: a phenomenon of older age and advanced liver disease.

Authors:  Johanna Delladetsima; Paraskevi Alexandrou; Konstantinos Giaslakiotis; Mina Psichogiou; Gregory Hatzis; Vana Sypsa; Dina Tiniakos
Journal:  Virchows Arch       Date:  2010-08-19       Impact factor: 4.064

Review 4.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

5.  Platelet-Derived Growth Factor Receptor α Contributes to Human Hepatic Stellate Cell Proliferation and Migration.

Authors:  Alexander Kikuchi; Tirthadipa Pradhan-Sundd; Sucha Singh; Shanmugam Nagarajan; Nick Loizos; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

6.  Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Authors:  Lance D Presser; Steven McRae; Gulam Waris
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

7.  Saikosaponin a and saikosaponin d inhibit proliferation and migratory activity of rat HSC-T6 cells.

Authors:  Ming Feng Chen; Chao Cheng Huang; Pei Shan Liu; Chang Han Chen; Li Yen Shiu
Journal:  J Med Food       Date:  2013-09       Impact factor: 2.786

Review 8.  Treatment of hepatic fibrosis: almost there.

Authors:  Efsevia Albanis; Rifaat Safadi; Scott L Friedman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 9.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

10.  Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver.

Authors:  Elke Van Rossen; Sara Vander Borght; Leo Adrianus van Grunsven; Hendrik Reynaert; Veerle Bruggeman; Rune Blomhoff; Tania Roskams; Albert Geerts
Journal:  Histochem Cell Biol       Date:  2008-12-04       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.